Fresenius is not currently merging into another company, but rather executing an internal structural transformation strategy known as Future Fresenius, focusing on streamlining its core healthcare business sectors like Fresenius Kabi and Fresenius Helios. Over recent years, the massive German healthcare conglomerate completed a major corporate transformation by changing the legal status of Fresenius Medical Care from a legally dependent subsidiary structure into an independent public stock corporation while retaining it under the group umbrella. Rather than pursuing external mergers, management concentrates on portfolio optimization, operational efficiency, and divesting non-core assets to reduce corporate debt levels. The organization continues to evaluate strategic partnerships and joint ventures within specific regional clinical markets, but its primary focus remains organic growth, digital transformation, and systemic operational improvements across its global health networks.